Michael R. Law

5.4k total citations
196 papers, 3.3k citations indexed

About

Michael R. Law is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael R. Law has authored 196 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Economics and Econometrics, 42 papers in General Health Professions and 36 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael R. Law's work include Health Systems, Economic Evaluations, Quality of Life (47 papers), Healthcare Policy and Management (39 papers) and Pharmaceutical Economics and Policy (32 papers). Michael R. Law is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (47 papers), Healthcare Policy and Management (39 papers) and Pharmaceutical Economics and Policy (32 papers). Michael R. Law collaborates with scholars based in Canada, United States and New Zealand. Michael R. Law's co-authors include Steven G. Morgan, Katy B. Kozhimannil, Kimberlyn McGrail, Lucy Cheng, Beth A Virnig, Dennis Ross‐Degnan, Stephen B. Soumerai, Jamie R. Daw, Irfan A. Dhalla and Alyce S. Adams and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Michael R. Law

170 papers receiving 3.1k citations

Peers

Michael R. Law
Anita K. Wagner United States
Alan Haycox United Kingdom
Jeff Luck United States
John Peabody United States
F. Zhang United States
Tim Mathes Germany
Frank Davidoff United States
Emma Harvey United Kingdom
Michael R. Law
Citations per year, relative to Michael R. Law Michael R. Law (= 1×) peers Jakob Kragstrup

Countries citing papers authored by Michael R. Law

Since Specialization
Citations

This map shows the geographic impact of Michael R. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Law more than expected).

Fields of papers citing papers by Michael R. Law

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Law. The network helps show where Michael R. Law may publish in the future.

Co-authorship network of co-authors of Michael R. Law

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Law. A scholar is included among the top collaborators of Michael R. Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Law. Michael R. Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makuza, Jean Damascène, Dahn Jeong, Michael R. Law, et al.. (2025). Hepatitis B Virus Care Cascade in Rwanda: A Population-based Study From 2016–2023. Clinical Infectious Diseases. 81(6). 1091–1101.
2.
Nethery, Elizabeth, Michael R. Law, Andrew Kotaska, Patricia A. Janssen, & Jennifer A. Hutcheon. (2023). The effect of changing screening practices and demographics on the incidence of gestational diabetes in British Columbia, 2005–2019. Canadian Medical Association Journal. 195(11). E396–E403. 13 indexed citations
3.
Cui, Zishan, Mohammad Karamouzian, Michael R. Law, et al.. (2023). The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis. International Journal of Mental Health and Addiction. 22(6). 4004–4020. 3 indexed citations
5.
Morrow, Richard L., Barbara Mintzes, Garry Gray, et al.. (2023). Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study. BMJ Open. 13(3). e068221–e068221. 2 indexed citations
6.
Connolly, Emilia, Zeus Aranda, Vincent K. Cubaka, et al.. (2023). The impact of COVID-19 and national pandemic responses on health service utilisation in seven low- and middle-income countries. Global Health Action. 16(1). 2178604–2178604. 10 indexed citations
7.
Grépin, Karen A., Celestin Hategeka, Mala Ali Mapatano, et al.. (2022). Assessing routine health information system performance during the tenth outbreak of Ebola virus disease (2018–2020) in the Democratic Republic of the Congo: A qualitative study in North Kivu. SHILAP Revista de lepidopterología. 2(7). e0000429–e0000429. 1 indexed citations
8.
Fulcher, Isabel, et al.. (2021). Syndromic surveillance using monthly aggregate health systems information data: methods with application to COVID-19 in Liberia. International Journal of Epidemiology. 50(4). 1091–1102. 10 indexed citations
9.
Suda, Katie J., et al.. (2021). Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis. BMJ Global Health. 6(12). e006874–e006874. 14 indexed citations
10.
Morrow, Richard L., Barbara Mintzes, Garry Gray, et al.. (2021). Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study. Clinical Therapeutics. 44(3). 374–388. 5 indexed citations
11.
Hung, Yuen Wai, Michael R. Law, Lucy Cheng, et al.. (2020). Impact of a free care policy on the utilisation of health services during an Ebola outbreak in the Democratic Republic of Congo: an interrupted time-series analysis. BMJ Global Health. 5(7). e002119–e002119. 18 indexed citations
12.
13.
Musabyimana, Angèle, Hinda Ruton, Erick Gaju, et al.. (2018). Assessing the perspectives of users and beneficiaries of a community health worker mHealth tracking system for mothers and children in Rwanda. PLoS ONE. 13(6). e0198725–e0198725. 26 indexed citations
14.
Sutherland, Jason M., Guiping Liu, Trafford Crump, & Michael R. Law. (2016). Paying for volume: British Columbia’s experiment with funding hospitals based on activity. Health Policy. 120(11). 1322–1328. 9 indexed citations
15.
Cheng, Lucy, et al.. (2016). The impact of medication reviews by community pharmacists. Journal of the American Pharmacists Association. 56(5). 513–520.e1. 29 indexed citations
16.
Gomes, Tara, Diana Martins, Lucy Cheng, et al.. (2015). The impact of policies to reduce blood glucose test strip utilization and costs in Canada. Canadian Journal of Public Health. 106(4). e210–e216. 5 indexed citations
17.
Morgan, Steve, Jamie R. Daw, & Michael R. Law. (2013). Rethinking Pharmacare in Canada. C.D. Howe Institute Commentary. 7 indexed citations
18.
Allin, Sara, Ahmed M. Bayoumi, Michael R. Law, & Audrey Laporte. (2013). Comparability of self-reported medication use and pharmacy claims data.. PubMed. 24(1). 3–9. 20 indexed citations
19.
Law, Michael R., et al.. (2013). Getting to know ArcGIS for desktop. 17 indexed citations
20.
McGrail, Kimberlyn, et al.. (2010). Correction: Research. Canadian Medical Association Journal. 182(8). 806–806. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026